Gujarat Terce Laboratories Limited (BOM:524314)

India flag India · Delayed Price · Currency is INR
43.50
+0.11 (0.25%)
At close: Jan 21, 2026
-44.41%
Market Cap341.96M
Revenue (ttm)501.95M
Net Income (ttm)-9.79M
Shares Out7.79M
EPS (ttm)-1.32
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,674
Average Volume2,400
Open43.00
Previous Close43.39
Day's Range40.21 - 45.00
52-Week Range37.20 - 87.80
Beta0.82
RSI43.94
Earnings DateFeb 4, 2026

About BOM:524314

Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, Codimol, Cefter, and Terflora brands. Gujarat Terce Laboratories Limited was incorporate... [Read more]

Industry Pharmaceutical Preparations
Founded 1985
Employees 244
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524314
Full Company Profile

Financial Performance

Financial Statements